Estimating the burden of congenital rubella syndrome in Costa Rica, 1996-2001

Pediatric Infectious Disease Journal

Volumn 26, Issue 5, 2007, Pages 382-386

  Jiménez, Gabriela ^a   Ávila Aguero, María L ^a,f   Morice, Ana ^b   Gutiérrez, Hazel ^a   Soriano, Alejandra ^a   Badilla, Xiomara ^c   Reef, Susan ^d   Castillo Solórzano, Carlos ^e  

^a National Children's Hospital   (Costa Rica)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c CAJA COSTARRICENSE DE SEGURO SOCIAL   (Costa Rica)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

^f Ministry of Health   (Costa Rica)

Author keywords

Compatible description; Congenital rubella syndrome; Incidence; Rubella; Surveillance

Indexed keywords

IMMUNOGLOBULIN M;

ANTIBODY DETECTION; ARTICLE; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; COSTA RICA; EPIDEMIC; FEMALE FERTILITY; FIRST TRIMESTER PREGNANCY; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SEROLOGY; STATISTICAL MODEL;

ADULT; COST OF ILLNESS; COSTA RICA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; RETROSPECTIVE STUDIES; RUBELLA SYNDROME, CONGENITAL; TIME FACTORS;

EID: 34249021075     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000260000.84792.9e     Document Type: Article

References (23)

1. Morice A, González L, Castillo-Solórzano C. Tendencias de la inmunidad a la rubéola en mujeres de edad fértil y pre-escolares en Costa Rica, 1969-1996. Acta Pediátrica Costarricense. 2005;19:13-18.
2. Morice A, Carvajal X, León M, et al. Acelerated rubella control and congenital rubella syndrome prevention strengthens measles eradication: the Costa Rican experience. J Infect Dis. 2003;187(Suppl 1):158-163.
3. Mencher GT, Madriz JJ. Research and expansion of services in the developing world: a Costa Rican experience. J Speech-Lang Pathol Audiol. 1999;23:184-204.
4. Zimmerman L, Reef S. Incidence of Congenital Rubella syndrome at a hospital serving a predominantly hispanic populatio, El Paso, Texas. Pediatrics. 2001;107:1-4.
5. Ávila-Agüero ML, Morice A, Castillo-Solórzano C, Soriano A, Ulloa-Gutiérrez R, Reef S. Síndrome de rubéola congénita en Costa Rica: importancia de la Vigilancia Activa. Ann Pediatr. 2005;62:43-47.
6. Council of State and Territorial Epidemiologist (CSTE). 199 Position Statements. Madison, WI: CSTE National Meeting; 1999. Position Statement ID-4.
7. Pan American Health Organization. Elimination of Rubella and Congenital Rubella Syndrome: Field Guide. Washington, DC: Scientific and Technical Publication No 606; 2005.
8. Holmes SJ, Orenstein WA. Rubella. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans: Epidemiology and Control. New York: Plenum; 1997:839-860.
9. Cutts FT, Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 1999;28:1176-1184.
10. Stray-Pedersen B. Economic evaluation of different vaccination programmes to prevent congenital rubella. NIPH Ann (Norway). 1982;46:115-119.
11. Banatvala JE, Brown DWG, Path FRC. Rubella. Lancet. 2004;363:1127-1137.
12. Reef S, Plotkin S, Cordero JF, et al. Preparing for elimination of Congenital Rubella syndrome: summary of a workshop on CRS elimination in the United States. Clin Infect Dis. 2000;31:85-95.
13. Orenstein WA, Preblud SR, Bart KJ, Hinman AR. Methods of assessing the impact of congenital rubella infection. Rev Infect Dis. 1985;7(Suppl 1):S22-S28.
14. Feigin RD, Cherry JD. Textbook of Pediatric Infectious Diseases. Vol 2, 5th ed. Philadelphia: Elsevier; 2004.
15. Cheffins T, Chan A, Keane RJ, Haan EA, Hall R. The impact of rubella immunization on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia. Br J Obstetr Gynaecol. 1998;105:998-1004.
16. Cutts FT, Robertson SE, Díaz-Ortega JL, Samuel R. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: burden of disease from CRS. Bull Health Organ. 1997;75:55-68.
17. Peckman C. Congenital rubella in the United Kingdom before 1970: the prevaccine era. Rev Infect Dis. 1985;7(Suppl 1):S11-S16.
18. Ulstrup J, Skaug JC, Stray-Pedersen B. A rubella epidemic in an unvaccinated pregnant population. I. Screening methods and serological results. Scan J Infect Dis. 1981;13:11-15.
19. Cochi SL, Edmonds LE, Dyer K, et al. Congenital rubella syndrome in the United States, 1970-1985: on the verge of elimination. Am J Epidemiol. 1989;129:349-361.
20. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982;2:781-784.
21. Gregg NM. Congenital cataract following German measles in the mother. Trans Ophtalmol Soc Australia. 1941;3:35-46.
22. Plotkin SA, Orenstein WA. Rubella vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia, PA: Elsevier; 2004:707-743.
23. Organización Panamericana de la Salud, Organización Mundial de la Salud. Resolución CD44. R1. 44° Consejo Directivo. 55a Sesión del Comité Regional. Washington DC: EUA; 2003.